Insider: Kewalramani Reshma CEO & President - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 98,278 | 0 | 98,278 |
| Value | $43,119,472.50 | $0.00 | $43,119,472.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/27/2026 | DDS | 1,725 | Direct | COM | $496.95 | $857,238.75 | 98,278 |
| 02/27/2026 | DDS | 3,278 | Direct | COM | $488.27 | $1,600,549.06 | 131,730 |
| 02/27/2026 | DDS | 240 | Direct | COM | $482.84 | $115,881.60 | 137,518 |
| 02/27/2026 | DDS | 120 | Direct | COM | $481.50 | $57,780.00 | 137,758 |
| 02/27/2026 | DDS | 400 | Direct | COM | $479.75 | $191,900.00 | 137,878 |
| 02/27/2026 | DDS | 460 | Direct | COM | $489.32 | $225,087.20 | 131,270 |
| 02/27/2026 | DDS | 2,510 | Direct | COM | $487.13 | $1,222,696.30 | 135,008 |
| 02/27/2026 | DDS | 5,995 | Direct | COM | $496.16 | $2,974,479.20 | 100,003 |
| 02/27/2026 | DDS | 2,725 | Direct | COM | $490.54 | $1,336,721.50 | 128,545 |
| 02/27/2026 | DDS | 15,580 | Direct | COM | $495.38 | $7,718,020.40 | 105,998 |
| 02/27/2026 | DDS | 3,498 | Direct | COM | $494.33 | $1,729,166.34 | 121,578 |
| 02/27/2026 | DDS | 949 | Direct | COM | $491.30 | $466,243.70 | 127,596 |
| 02/27/2026 | DDS | 2,520 | Direct | COM | $493.29 | $1,243,090.80 | 125,076 |
| 08/06/2025 | AAP | 4,290 | Direct | COM | $389.08 | $1,669,153.20 | 110,258 |
| 08/06/2025 | AAP | 5,710 | Direct | COM | $389.95 | $2,226,614.50 | 115,968 |
| 11/08/2024 | DDS | 15,198 | Direct | COM | $515.00 | $7,826,970.00 | 75,772 |
| 07/30/2024 | DDS | 15,202 | Direct | COM | $505.00 | $7,677,010.00 | 90,970 |
| 05/24/2024 | DDS | 1,565 | Direct | COM | $457.00 | $715,205.00 | 121,374 |
| 05/20/2024 | DDS | 15,202 | Direct | COM | $447.00 | $6,795,294.00 | 121,374 |
| 12/15/2023 | DDS | 17,135 | Direct | COM | $407.00 | $6,973,945.00 | 108,711 |
| 12/13/2023 | DDS | 5,098 | Direct | COM | $397.00 | $2,023,906.00 | 108,711 |
| 11/13/2023 | DDS | 5,097 | Direct | COM | $377.00 | $1,921,569.00 | 113,809 |
| 07/17/2023 | DDS | 7,828 | Direct | COM | $355.00 | $2,778,940.00 | 118,906 |
| 04/27/2023 | DDS | 1,611 | Direct | COM | $338.69 | $545,629.59 | 128,358 |
| 04/27/2023 | DDS | 1,668 | Direct | COM | $339.43 | $566,169.24 | 126,690 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research